SEOUL (Reuters) – South Korea’s LG Chem Ltd said in a regulatory filing on Tuesday that it is investing $566 million to acquire U.S. firm Aveo Pharmaceuticals Inc and enter the U.S.
anti-cancer drug market.
The deal is expected to close in the first quarter of 2023, LG Chem said.
(Reporting by Joyce Lee; Editing by Kirsten Donovan)
